The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: recent evolution and open questions

P Deltenre, A Zanetto, D Saltini, C Moreno… - Hepatology, 2023 - journals.lww.com
In selected patients with cirrhosis and ascites, transjugular intrahepatic portosystemic shunt
(TIPS) placement improves control of ascites and may reduce mortality. In this review, we …

The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites

G Garcia-Tsao - Nature Clinical Practice Gastroenterology & …, 2006 - nature.com
Cirrhotic ascites results from sinusoidal hypertension and sodium retention, which is
secondary to a decreased effective arterial blood volume. Transjugular intrahepatic …

Long‐term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion

HK Tan, PD James, KW Sniderman… - … of gastroenterology and …, 2015 - Wiley Online Library
Abstract Background and Aim Transjugular intrahepatic portosystemic shunt (TIPS) is
indicated for the treatment of refractory ascites in cirrhosis. The long‐term outcome of TIPS …

Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure

P Michl - Scandinavian journal of gastroenterology, 2000 - Taylor & Francis
Background: A transjugular intrahepatic portosystemic shunt (TIPS) is increasingly being
used for treatment of patients with refractory ascites and functional renal failure. In contrast …

[HTML][HTML] Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival

F Piecha, UK Radunski, AK Ozga, D Steins, A Drolz… - Jhep Reports, 2019 - Elsevier
Background & Aims Refractory ascites is the main reason for the implantation of a
transjugular intrahepatic portosystemic shunt (TIPS) in liver cirrhosis, but ascites control by …

Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites

M Deschênes, MP Dufresne, B Bui… - Official journal of the …, 1999 - journals.lww.com
Objective: Transjugular intrahepatic portosystemic shunt (TIPS) is used increasingly as a
treatment for refractory ascites. The aim of the present study was to determine the prognostic …

Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis

EH Forrest, AJ Stanley, DN Redhead… - Alimentary …, 1996 - Wiley Online Library
Background: Transjugular intrahepatic portosystemic stent shunts (TIPSS) have been used
successfully to reduce portal pressure in the context of variceal haemorrhage. Recent …

Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience

F Lodato, A Berzigotti, A Lisotti, F Azzaroli… - Scandinavian journal …, 2012 - Taylor & Francis
Background. The presence of refractory ascites is a common indication for transjugular
intrahepatic portosystemic shunt (TIPS). Different models have been proposed for the …

Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data

F Salerno, C Cammà, M Enea, M Rössle, F Wong - Gastroenterology, 2007 - Elsevier
Background & Aims: Several randomized controlled trials have compared a transjugular
intrahepatic portosystemic shunt (TIPS) with large-volume paracentesis in cirrhotic patients …

Prophylactic use of transjugular intrahepatic portosystemic shunt aids in the treatment of refractory ascites: metaregression and trial sequential meta-analysis

RP Chen, XJZ Ge, ZM Huang, XH Ye… - Journal of Clinical …, 2014 - journals.lww.com
Background: TIPS is more effective for refractory ascites versus large-volume paracentesis.
At present, however, the survival advantage is not clear within populations of …